As
Asklepios
RTP NCFounded 2001200 employees
Private CapbiotechPrivateGenetic Medicine
Platform: Pro10 AAV
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ASK-5918 | ASK-5918 | Phase 2/3 | 1 | GLP-1R | DravetSLE | ||
| ASK-6688 | ASK-6688 | NDA/BLA | 2 | SGLT2 | ALLWilms |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)